108 related articles for article (PubMed ID: 3081477)
1. Low-dose PGI2 prevents monocrotaline-induced thromboxane production and lung injury.
Czer GT; Marsh J; Konopka R; Moser KM
J Appl Physiol (1985); 1986 Feb; 60(2):464-71. PubMed ID: 3081477
[TBL] [Abstract][Full Text] [Related]
2. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
[TBL] [Abstract][Full Text] [Related]
3. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin inhibits 5-hydroxytryptamine release but stimulates thromboxane synthesis during cardiopulmonary bypass.
Aznavoorian SA; Utsunomiya T; Krausz MM; Cohn LH; Shepro D; Hechtman HB
Prostaglandins; 1983 Apr; 25(4):557-70. PubMed ID: 6348886
[TBL] [Abstract][Full Text] [Related]
5. Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.
Stenmark KR; Morganroth ML; Remigio LK; Voelkel NF; Murphy RC; Henson PM; Mathias MM; Reeves JT
Am J Physiol; 1985 Jun; 248(6 Pt 2):H859-66. PubMed ID: 3923843
[TBL] [Abstract][Full Text] [Related]
6. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
Cuiper LL; Price PV; Christman BW
J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
8. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
White SM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of prostacyclin used to perfuse isolated lung lobes.
Krausz MM; Utsunomiya T; Levine LL; Dunham B; Shepro D; Hechtman HB
Am J Physiol; 1982 May; 242(5):H745-50. PubMed ID: 7044149
[TBL] [Abstract][Full Text] [Related]
11. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
Molteni A; Ward WF; Ts'ao CH; Hinz JM
Biochem Pharmacol; 1989 Aug; 38(15):2411-9. PubMed ID: 2547380
[TBL] [Abstract][Full Text] [Related]
12. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617.
Molteni A; Ward WF; Ts'ao C; Solliday NH
Arch Int Pharmacodyn Ther; 1988; 291():21-40. PubMed ID: 3129998
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion.
Peterson MB; Huttemeier PC; Zapol WM; Martin EG; Watkins WD
Am J Physiol; 1982 Sep; 243(3):H471-9. PubMed ID: 7051860
[TBL] [Abstract][Full Text] [Related]
15. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
Langleben D; Carvalho AC; Reid LM
Am Rev Respir Dis; 1986 May; 133(5):789-91. PubMed ID: 3085563
[TBL] [Abstract][Full Text] [Related]
16. Monocrotaline pneumotoxicity in mice.
Molteni A; Ward WF; Ts'ao CH; Solliday NH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(3):149-55. PubMed ID: 2570481
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary prostacyclin production with increased flow and sympathetic stimulation.
Ellsworth ML; Gregory TJ; Newell JC
J Appl Physiol Respir Environ Exerc Physiol; 1983 Oct; 55(4):1225-31. PubMed ID: 6415017
[TBL] [Abstract][Full Text] [Related]
18. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
White SM; Roth RA
Toxicol Appl Pharmacol; 1988 Dec; 96(3):465-75. PubMed ID: 2974653
[TBL] [Abstract][Full Text] [Related]
20. Effects of thromboxane synthase inhibition on air emboli lung injury in sheep.
Fukushima M; Kobayashi T
J Appl Physiol (1985); 1986 Jun; 60(6):1828-33. PubMed ID: 3755131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
